Vasc Health Risk Manag Volume 2(1); March 2006

Other Issues: previous | next | latest | archive

Volume 2(1); March 2006

Editorial Foreword

Incidence of Stroke After Myocardial Infarction

Reza Tabrizchi

Vasc Health Risk Manag. 2006 March; 2(1): 1–2. Published online 2006 March.

PMCID: PMC1993971

| Full Text | PDF–37K |

Reviews

Treatment of Severe Sepsis: Where Next? Current and Future Treatment Approaches After the Introduction of Drotrecogin Alfa

Todd W Rice

Vasc Health Risk Manag. 2006 March; 2(1): 3–18. Published online 2006 March.

PMCID: PMC1993976

| Abstract | Full Text | PDF–135K |

Noninvasive Assessment of Preclinical Atherosclerosis

Helen A Lane, Jamie C Smith, and J Stephen Davies

Vasc Health Risk Manag. 2006 March; 2(1): 19–30. Published online 2006 March.

PMCID: PMC1993970

| Abstract | Full Text | PDF–113K |

Complementary Therapy to Target LDL Cholesterol: The Role of the Ezetimibe/Simvastatin Combination

Ryan C Neal and Peter H Jones

Vasc Health Risk Manag. 2006 March; 2(1): 31–38. Published online 2006 March.

PMCID: PMC1993974

| Abstract | Full Text | PDF–102K |

Platelet Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndromes and Percutaneous Coronary Intervention: Glycoprotein IIb/IIIa Inhibitors, Clopidogrel, or Both?

Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, and Gregory A Volturo

Vasc Health Risk Manag. 2006 March; 2(1): 39–48. Published online 2006 March.

PMCID: PMC1993977

| Abstract | Full Text | PDF–112K |

Ximelagatran: Direct Thrombin Inhibitor

Shir-Jing Ho and Tim A Brighton

Vasc Health Risk Manag. 2006 March; 2(1): 49–58. Published online 2006 March.

PMCID: PMC1993972

| Abstract | Full Text | PDF–117K |

Insulin Glargine in the Treatment of Type 1 and Type 2 Diabetes

Anthony H Barnett

Vasc Health Risk Manag. 2006 March; 2(1): 59–67. Published online 2006 March.

PMCID: PMC1993975

| Abstract | Full Text | PDF–167K |

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes

Catherine A Schnabel, Matthew Wintle, and Orville Kolterman

Vasc Health Risk Manag. 2006 March; 2(1): 69–77. Published online 2006 March.

PMCID: PMC1993968

| Abstract | Full Text | PDF–135K |

Effects of Eprosartan on Target Organ Protection

Alejandro de la Sierra

Vasc Health Risk Manag. 2006 March; 2(1): 79–85. Published online 2006 March.

PMCID: PMC1993973

| Abstract | Full Text | PDF–84K |

Original Research

Evaluation of Efficacy and Safety of Fixed Dose Lovastatin and Niacin^ER Combination in Asian Indian Dyslipidemic Patients: A Multicentric Study

Manoj Sharma, Deepika R Sharma, Vikram Singh, RB Panwar, HS Hira, Bishav Mohan, Naveen Kumar, SK Sharma, and Rajeev Gupta

Vasc Health Risk Manag. 2006 March; 2(1): 87–93. Published online 2006 March.

PMCID: PMC1993969

| Abstract | Full Text | PDF–84K |

Other Issues: previous | next | latest | archive

		Other Issues: previous \| next \| latest \| archive Volume 2(1); March 2006 Editorial Foreword Incidence of Stroke After Myocardial Infarction Reza Tabrizchi Vasc Health Risk Manag. 2006 March; 2(1): 1–2. Published online 2006 March. PMCID: PMC1993971 \| Full Text \| PDF–37K \| Reviews Treatment of Severe Sepsis: Where Next? Current and Future Treatment Approaches After the Introduction of Drotrecogin Alfa Todd W Rice Vasc Health Risk Manag. 2006 March; 2(1): 3–18. Published online 2006 March. PMCID: PMC1993976 \| Abstract \| Full Text \| PDF–135K \| Noninvasive Assessment of Preclinical Atherosclerosis Helen A Lane, Jamie C Smith, and J Stephen Davies Vasc Health Risk Manag. 2006 March; 2(1): 19–30. Published online 2006 March. PMCID: PMC1993970 \| Abstract \| Full Text \| PDF–113K \| Complementary Therapy to Target LDL Cholesterol: The Role of the Ezetimibe/Simvastatin Combination Ryan C Neal and Peter H Jones Vasc Health Risk Manag. 2006 March; 2(1): 31–38. Published online 2006 March. PMCID: PMC1993974 \| Abstract \| Full Text \| PDF–102K \| Platelet Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndromes and Percutaneous Coronary Intervention: Glycoprotein IIb/IIIa Inhibitors, Clopidogrel, or Both? Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, and Gregory A Volturo Vasc Health Risk Manag. 2006 March; 2(1): 39–48. Published online 2006 March. PMCID: PMC1993977 \| Abstract \| Full Text \| PDF–112K \| Ximelagatran: Direct Thrombin Inhibitor Shir-Jing Ho and Tim A Brighton Vasc Health Risk Manag. 2006 March; 2(1): 49–58. Published online 2006 March. PMCID: PMC1993972 \| Abstract \| Full Text \| PDF–117K \| Insulin Glargine in the Treatment of Type 1 and Type 2 Diabetes Anthony H Barnett Vasc Health Risk Manag. 2006 March; 2(1): 59–67. Published online 2006 March. PMCID: PMC1993975 \| Abstract \| Full Text \| PDF–167K \| Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes Catherine A Schnabel, Matthew Wintle, and Orville Kolterman Vasc Health Risk Manag. 2006 March; 2(1): 69–77. Published online 2006 March. PMCID: PMC1993968 \| Abstract \| Full Text \| PDF–135K \| Effects of Eprosartan on Target Organ Protection Alejandro de la Sierra Vasc Health Risk Manag. 2006 March; 2(1): 79–85. Published online 2006 March. PMCID: PMC1993973 \| Abstract \| Full Text \| PDF–84K \| Original Research Evaluation of Efficacy and Safety of Fixed Dose Lovastatin and Niacin^ER Combination in Asian Indian Dyslipidemic Patients: A Multicentric Study Manoj Sharma, Deepika R Sharma, Vikram Singh, RB Panwar, HS Hira, Bishav Mohan, Naveen Kumar, SK Sharma, and Rajeev Gupta Vasc Health Risk Manag. 2006 March; 2(1): 87–93. Published online 2006 March. PMCID: PMC1993969 \| Abstract \| Full Text \| PDF–84K \|
		Other Issues: previous \| next \| latest \| archive
		Articles from Vascular Health and Risk Management are provided here courtesy of Dove Press Write to PMC \| PMC Home \| PubMed NCBI \| U.S. National Library of Medicine NIH \| Department of Health and Human Services Privacy Policy \| Disclaimer \| Freedom of Information Act